Show simple item record

dc.contributor.authorFoster, Cortney
dc.contributor.authorBagdure, Dayanand
dc.contributor.authorCuster, Jason
dc.contributor.authorHolloway, Adrian
dc.contributor.authorRycus, Peter
dc.contributor.authorDay, Jenni
dc.contributor.authorBhutta, Adnan
dc.date.accessioned2021-10-28T12:45:11Z
dc.date.available2021-10-28T12:45:11Z
dc.date.issued2021-10-08
dc.identifier.urihttp://hdl.handle.net/10713/16967
dc.description.abstractBackground: Extracorporeal membrane oxygenation (ECMO) is increasingly utilized for pediatric sepsis unresponsive to steroids and inotropic support. Outcomes of children with sepsis are influenced by the type of pathogen causing their illness. Objective: To determine if the outcomes of children with Staphylococcus aureus sepsis receiving ECMO differed according to microbial sensitivity (Methicillin-resistant Staphylococcus aureus [MRSA] vs. Methicillin-sensitive Staphylococcus aureus [MSSA]). Methods: Retrospective case-matched cohort study of children (0-<18 years) with Staphylococcus aureus sepsis reported to the ELSO registry from more than 995 centers. Inclusion criteria were age 0-18 years, laboratory diagnosis of Staphylococcal infection, clinical diagnosis of sepsis, and ECMO deployment. Exclusion criteria were no laboratory diagnosis of Staphylococcal infection. We compared patient demographics, pre-ECMO management and outcomes of those with MRSA vs. MSSA using Chi-Square test, with independent samples t-test used to test to compare continuous variables. Results: In our study cohort of 308 patients, 160 (52%) had MSSA and 148 (48%) MRSA with an overall survival rate of 41.5%. There were no differences in the age group (p = 0.76), gender distribution (p = 0.1) or racial distribution (p = 0.58) between the two groups. P value for racial distribution should be 0.058. There were 91 (56.8%) deaths in the MSSA group and 89 (60.1%) deaths (p = 0.56) in the MRSA group. Duration on ECMO (p = 0.085) and the time from intubation to ECMO (p = 0.37) were also similar in the two groups. Survival with MSSA sepsis and MRSA sepsis did not improve significantly over the 20 years evaluated despite an increase in ECMO utilization. Conclusion: In this multi-center retrospective study, there were no differences in outcomes for children receiving ECMO support with Staphylococcus aureus sepsis according to microbial methicillin sensitivity. There was no significant increase in survival among patients with MRSA and MSSA infections receiving ECMO in the last 20 years.en_US
dc.description.urihttps://doi.org/10.3389/fped.2021.706638en_US
dc.language.isoenen_US
dc.publisherFrontiers Media S.A.en_US
dc.relation.ispartofFrontiers in Pediatricsen_US
dc.rightsCopyright © 2021 Foster, Bagdure, Custer, Holloway, Rycus, Day and Bhutta.en_US
dc.subjectECMOen_US
dc.subjectMRSAen_US
dc.subjectMSSAen_US
dc.subjectoutcomesen_US
dc.subjectpediatricen_US
dc.subjectsepsisen_US
dc.titleOutcomes of Pediatric Patients With Sepsis Related to and Methicillin-Resistant Infections Requiring Extracorporeal Life Support: An ELSO Database Studyen_US
dc.typeArticleen_US
dc.identifier.doi10.3389/fped.2021.706638
dc.identifier.pmid34692605
dc.source.volume9
dc.source.beginpage706638
dc.source.endpage
dc.source.countrySwitzerland


This item appears in the following Collection(s)

Show simple item record